GUD Knight Therapeutics Inc.

7.892USD11.29 CAD · TSX-2.34%Mkt Cap: 775.62M USDP/E: 70.56

Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America. The company offers Minjuvi for relapsed or refr…